NewswireToday - /newswire/ -
Winston-Salem, NC, United States, 2007/05/03 - SmallCapReview.com, a leading small-cap stock information site, introduces Smith Microdevices (Nasdaq: SMDI), JAKKS Pacific (Nasdaq: JAKK) and Trimeris (Nasdaq: TRMS) to its database of subscribers and its website audience.
Sirenza Microdevices (Nasdaq: SMDI) is a supplier of radio frequency (RF) components. Headquartered in Broomfield, Colorado, with operations in China, Germany, and the U.S., Sirenza Microdevices and its subsidiary, Premier Devices, design and develop RF components for the commercial communications, consumer, and aerospace and defense equipment markets.
JAKKS Pacific (Nasdaq: JAKK) develops, produces, and markets consumer products, including toys and related products, stationery and writing instruments, and pet toys and related products in the United States and internationally. Its traditional toys consist of action figures and accessories, including licensed characters, principally based on World Wrestling Entertainment, and the Dragon Ball and Pokemon franchises; and toy vehicles comprising Road Champs die-cast collectibles, Fly Wheels, and RC Racers & MXS toy vehicles and accessories.
Trimeris (Nasdaq: TRMS) is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. FUZEON, approved in the U.S., Canada and European Union, is the first in a new class of anti-HIV drugs called fusion inhibitors. Trimeris is developing FUZEON and future generations of peptide fusion inhibitors in collaboration with F. Hoffmann-La Roche Ltd.
SmallCapReview.com news is a Free Newsletter sent to subscribers.
Features available at SmallCapReview.com include in-depth profiles of select Small-Cap and Penny Stocks, an exhaustive research page, tech charts, and daily news on companies and trends in the small-cap market.
Disclosure: No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapReview.com will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on our website. SmallCapReview.com has not been compensated by any of the companies mentioned in this release nor do we hold shares in the companies at this time.